Acurx Pharmaceuticals ACXP
NASDAQ ACXP
$1.14 -0.01 (-0.87%)
At close: Oct 22, 2026 · 4:00 PM EDT

Acurx Pharmaceuticals (ACXP) Other Non-Current Assets (2022)

Updated

Acurx Pharmaceuticals (ACXP) reported Other Non-Current Assets of $50,247 for Q2 2022.

Analysis

Acurx Pharmaceuticals (ACXP) Other Non-Current Assets (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 7.48 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 15.10 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 10.73 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 19.60 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 5.93 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn -
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 12.98 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn 4.75 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 9.94 Bn
10 Acurx Pharmaceuticals 5.34 Mn -28.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 50,247.00
API Access

Acurx Pharmaceuticals Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=ACXP&period=max&api_key=YOUR_API_KEY